The psychosis continuum: Testing a bifactor model of psychosis in a general population sample

Schizophrenia Bulletin

Volumn 43, Issue 1, 2017, Pages 133-141

  Shevlin, Mark ^a   McElroy, Eoin ^a   Bentall, Richard P ^b   Reininghaus, Ulrich ^c,d   Murphy, Jamie ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; COGNITIVE DEFECT; DEPRESSION; DISORIENTATION; HUMAN; MAJOR CLINICAL STUDY; MANIA; MOTOR RETARDATION; NEGATIVE SYNDROME; POSITIVE SYNDROME; PRIORITY JOURNAL; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; STATISTICAL MODEL; ADOLESCENT; CLASSIFICATION; FACTOR ANALYSIS; FEMALE; MALE; PATHOPHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MODELS, STATISTICAL; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; YOUNG ADULT;

EID: 85014275208     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbw067     Document Type: Article

References (71)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Publishing; 2013.
2. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems (10th revision ed.). Geneva, Switzerland: World Health Organization; 1992.
3. Kraepelin E. Psychiatry: A Textbook for Students and Physicians. Volume 1: General Psychiatry. Canton, MA: Watson Publishing International; 1899/1990.
4. Read J, Dillon J. Models of Madness. Hove, East Sussex: Routledge; 2013.
5. van Os J. "Schizophrenia" does not exist. BMJ. 2016;352:i375.
6. Regier DA, Narrow WE, Clarke DE, et al. DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry. 2013;170:59-70.
7. Kessler RC, Chiu WT, Demler O, Walters EE. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62:617-627.
8. Lichtenstein P, Yip BH, Bjork C, et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet. 2009;373:234-239.
9. Craddock N, Owen M. The beginning of the end for the Kraepelinian dichotomy. Br J Psychiatry. 2005;186:364-366.
10. Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421-427.
11. Bentall RP. Madness Explained: Psychosis and Human Nature. London, UK: Penguin; 2003.
12. Fleming S, Shevlin M, Murphy J, Joseph S. Psychosis within dimensional and categorical models of mental illness. Psychosis. 2014;6:4-15.
13. Kotov R, Chang SW, Fochtmann LJ, et al. Schizophrenia in the internalizing-externalizing framework: a third dimension? Schizophr Bull. 2011;37:1168-1178.
14. Wright AGC, Krueger R, Hobbs MJ, Markon KE, Eaton NR, Slade T. The structure of psychopathology: toward an expanded quantitative empirical model. J Abnorm Psychol. 2013;122:281-294.
15. Eaton NR, Rodriguez-Seijas C, Carragher N, Krueger RF. Transdiagnostic factors of psychopathology and substance use disorders: a review. Soc Psychiatry Psychiatr Epidemiol. 2015;50:171-182.
16. Carragher N, Krueger RF, Eaton NR, Slade T. Disorders without borders: current and future directions in the metastructure of mental disorders. Soc Psychiatry Psychiatr Epidemiol. 2015;50:339-350.
17. Berrios GE, Beer D. Unitary psychosis concept. In: Berrios G, Porter R, eds. A History of Clinical Psychiatry. London, UK: Athlone Press; 1995: 280-291.
18. Tamminga CA, Pearlson G, Keshavan M, Sweeney J, Clementz B, Thaker G. Bipolar and schizophrenia network for intermediate phenotypes: outcomes across the psychosis continuum. Schizophr Bull. 2014;40(suppl 2): S131-S137.
19. Torrey EF, Miller J, Rawlings R, Yolken RH. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr Res. 1997;28:1-38.
20. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry. 2002;159:1080-1092.
21. Bentall RP, de Sousa P, Varese F, et al. From adversity to psychosis: pathways and mechanisms from specific adversities to specific symptoms. Soc Psychiatry Psychiatr Epidemiol. 2014;49:1011-1022.
22. Johnstone E, Crow T, Frith CD, Owens D. The Northwick Park 'functional psychosis' study: diagnosis and treatment response. Lancet. 1988;ii:119-125.
23. Emsley R, Rabinowitz J, Torreman M. The factor structure for the Positive and Negative Syndrome Scale (PANSS) in recent-onset psychosis. Schizophr Res. 2003;61:47-57.
24. Stefanovics EA, Elkis H, Zhening L, Zhang XY, Rosenheck RA. A cross-national factor analytic comparison of three models of PANSS symptoms in schizophrenia. Psychiatry Res. 2014;219:283-289.
25. Demjaha A, Morgan K, Morgan C, et al. Combining dimensional and categorical representation of psychosis: the way forward for DSM-V and ICD-11? Psychol Med. 2009;39:1943-1955.
26. Reise SP, Moore TM, Haviland MG. Bifactor models and rotations: exploring the extent to which multidimensional data yield univocal scale scores. J Pers Assess. 2010;92:544-559.
27. Reininghaus U, Priebe S, Bentall RP. Testing the psychopathology of psychosis: evidence for a general psychosis dimension. Schizophr Bull. 2013;39:884-895.
28. Reininghaus U, Böhnke JR, Hosang GM, et al. Probing the boundaries of the Kraepelinian dichotomy: evidence for a transdiagnostic psychosis spectrum encompassing schizophrenia and bipolar disorder [published online ahead of print March 17, 2016]. Brit J Psychiatry. doi:10.1192/bjp. bp.115.167882.
29. David AS. Why we need more debate on whether psychotic symptoms lie on a continuum with normality. Psychol Med. 2010;40:1935-1942.
30. Lawrie SM, Hall J, Owens DGC, Johnstone EC. The 'continuum of psychosis': scientifically unproven and clinically impractical. Br J Psychiatry. 2010;197:423-425.
31. Chapman LJ, Chapman JP. Scales for rating psychotic and psychotic-like experiences as continua. Schizophr Bull. 1980;6:477-489.
32. Claridge GS. Can a disease model of schizophrenia survive? In: Bentall RP, ed. Reconstructing Schizophrenia. London, UK: Routledge; 1990:157-183.
33. van Os J, Hanssen M, Bijl RV, Ravelli A. Strauss (1969) revisited: a psychosis continuum in the general population? Schizophr Res. 2000;45:11-20.
34. Linscott RJ, van Os J. Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. Annu Rev Clin Psychol. 2010;6:391-419.
35. Chapman LJ, Chapman JP, Kwapil TR, Eckblad M, Zinser MC. Putatively psychosis-prone subjects 10 years later. J Abnorm Psychol. 1994;103:171-183.
36. Linscott RJ, van Os J. An updated and conservative systematic review and meta-analysis of epidemiological evidence on psychotic experiences in children and adults: on the pathway from proneness to persistence to dimensional expression across mental disorders. Psychol Med. 2013;43:1133-1149.
37. van Os J, Linscott RJ, Myin-Germeys I, Delespaul P, Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis pronenesspersistence- impairment model of psychotic disorder. Psychol Med. 2009;39:179-195.
38. The International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature. 2009;460:748-752.
39. Lenzenwenger MF. Schizotypy and Schizophrenia. New York, NY: Guilford; 2010.
40. Daneluzzo E, Stratta P, Di Tommaso S, Pacifico R, Riccardi I, Rossi A. Dimensional, non-taxonic latent structure of psychotic symptoms in a student sample. Soc Psychiatry Psychiatr Epidemiol. 2009;44:911-916.
41. Bentall RP, Claridge GS, Slade PD. The multidimensional nature of schizotypal traits: a factor analytic study with normal subjects. Br J Clin Psychol. 1989;28:363-375.
42. Claridge G, McCreery C, Mason O, et al. The factor structure of "schizotypal' traits: a large replication study. Br J Clin Psychol. 1996;35:103-115.
43. Reynolds CA, Raine A, Mellingen K, Venables PH, Mednick SA. Three-factor model of schizotypal personality: invariance across culture, gender, religious affiliation, family adversity, and psychopathology. Schizophr Bull. 2000;26:603-618.
44. Venables PH, Rector NA. The content and structure of schizotypy: a study using confirmatory factor analysis. Schizophr Bull. 2000;26:587-602.
45. Mason O. A confirmatory factor analysis of the structure of schizotypy. Eur J Personal. 1995;9:271-281. doi:10.1002/ per.2410090404.
46. Preti A, Corrias I, Gabbrielli M, et al. The independence of schizotypy from affective temperaments- A combined confirmatory factor analysis of SPQ and the short TEMPS-A. Psychiatry Res. 2015;225:145-156.
47. Raine A. The SPQ: a scale for the assessment of schizotypal personality based on DSM-III-R criteria. Schizophr Bull. 1991;17:555-564.
48. Akiskal HS, Benazzi F, Perugi G, Rihmer Z. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. J Affect Disord. 2005;85:245-258.
49. Grant BF, Dawson DA. Introduction to the national epidemiologic survey on alcohol and related conditions. Alcohol Health Res World. 2006;29:74.
50. Grant B, Kaplan K. Source and Accuracy Statement for the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2005.
51. Grant B, Kaplan K, Shepard J, Moore T. Source and Accuracy Statement for Wave 1 of the 2001-2002 National Epidemiologic Survey on Alcohol and Related Conditions. Bethesda, MD: National Institute on Alcohol Abuse and Alcoholism; 2003.
52. Grant BF, Dawson DA, Stinson FS, Chou PS, Kay W, Pickering R. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of alcohol consumption, tobacco use, family history of depression and psychiatric diagnostic modules in a general population sample. Drug Alcohol Depend. 2003;71:7-16.
53. Grant BF, Dawson D. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV). Rockville, MD: National Institute on Alcohol Abuse and Alcoholism; 2000.
54. Grant BF, Harford TC, Dawson DA, Chou PS, Pickering RP. The Alcohol Use Disorder and Associated Disabilities Interview schedule (AUDADIS): reliability of alcohol and drug modules in a general population sample. Drug Alcohol Depend. 1995;39:37-44.
55. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:261.
56. Ahmed AO, Green BA, Buckley PF, McFarland ME. Taxometric analyses of paranoid and schizoid personality disorders. Psychiatry Res. 2012;196:123-132.
57. Ruan WJ, Goldstein RB, Chou SP, et al. The Alcohol Use Disorder and Associated Disabilities Interview Schedule-IV (AUDADIS-IV): reliability of new psychiatric diagnostic modules and risk factors in a general population sample. Drug Alcohol Depend. 2008;92:27-36.
58. Muthén LK, Muthen B. Mplus 6.0. Los Angeles, CA: Muthén & Muthén; 2010.
59. Brown TA. Confirmatory Factor Analysis for Applied Research. New York, NY: Guilford Press; 2006.
60. Flora DB, Curran PJ. An empirical evaluation of alternative methods of estimation for confirmatory factor analysis with ordinal data. Psychol Methods. 2004;9:466-491.
61. Bentler PM. Comparative fit indexes in structural models. Psychol Bull. 1990;107:238-246.
62. Tucker LR, Lewis C. A reliability coefficient for maximum likelihood factor analysis. Psychometrika. 1973;38:1-10.
63. Steiger JH. Structural model evaluation and modification: an interval estimation approach. Multivariate Behav Res. 1990;25:173-180.
64. Jöreskog KG, Sörbom D. LISREL 8: Structural Equation Modeling With the SIMPLIS Command Language. Chicago, IL: Scientific Software; 1993.
65. Yu CY. Evaluating cutoff criteria of model fit indices for latent variable models with binary and continuous outcomes [Doctoral dissertation]. Los Angeles, CA: University of California Los Angeles; 2002.
66. Voruganti L, Awad AG. Neuroleptic dysphoria: towards a new synthesis. Psychopharmacology. 2004;171:121-132.
67. Artaloytia JF, Arango C, Lahti A, et al. Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry. 2006;163:488-493.
68. Caspi A, Houts RM, Belsky DW, et al. The p Factor: One General Psychopathology Factor in the Structure of Psychiatric Disorders? Clin Psychol Sci. 2014;2:119-137.
69. Lahey BB, Applegate B, Hakes JK, Zald DH, Hariri AR, Rathouz PJ. Is there a general factor of prevalent psychopathology during adulthood? J Abnorm Psychol. 2012;121:971-977.
70. Kovas Y, Plomin R. Learning abilities and disabilities: generalist genes, specialist environments. Curr Dir Psychol Sci. 2007;16:284-288.
71. Maul A. Method effects and the meaning of measurement. Front Psychol. 2013;4:169.